.Merck & Co.'s long-running effort to land a blow on tiny cell bronchi cancer cells (SCLC) has ac...
.Some patients along with non-small cell bronchi cancer cells (NSCLC) possess anomalies in a genetic...
.MBX has actually expanded plans to absorb over $136 thousand coming from its IPO as the biotech aim...
.Relay Therapies has beaten its own survival goal in a first-in-human bust cancer cells research, pl...
.AstraZeneca has made use of expert system to develop a special biomarker for its Daiichi Sankyo-par...
.AstraZeneca execs say they are "certainly not concerned" that the failure of tozorakimab in a stage...
.Welcome to today's Chutes & Ladders, our roundup of significant management hirings, firings and ...
.After uncovering plannings to strike the U.S. public markets less than a month ago, Zenas Biopharma...
.Psyence Biomedical is paying $500,000 in allotments to acquire fellow psilocybin-based biotech Clai...
.Five months after signing off on Energy Rehabs' Pivya as the very first brand new treatment for eas...